HBIO   $0.4593  2.57% Market Closed

Harvard Bioscience, Inc.
Total Cash 4.05M
totalCashPerShare 0.093
EBITDA 3.61M
Total Debt 41.45M
quickRatio 0.731
currentRatio 2.053
Total Revenue 101.12M
debtToEquity 61.64
Revenue/Share 2.35
ROA -0.01623
ROE -0.14972
grossProfits
freeCashflow 11.31M
operatingCashflow 9.22M
earningsGrowth
revenueGrowth -0.197
grossMargins 0.58702
ebitdaMargins 0.03568
operatingMargins -0.07243
profitMargins -0.10559
enterpriseValue 160.39M
forwardPE 18.8
floatShares 38.22M
sharesOutstanding 43.61M
sharesShort 350.56K
sharesShortPriorMonth 429.12K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.74%
Short Ratio help_outline 2.69%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.542
Price To Book help_outline 1.83
earningsQuarterlyGrowth
netIncomeToCommon -10.68M
trailingEps -0.29%
forwardEps 0.15%
enterpriseToEbitda 44.45
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.03 3Q 2024
institutionsCount 142
lastUpdated Nov. 7, 2024, 9:27 a.m.